SpiderFX embolic protection device
Covidien (NYSE:COV) landed 510(k) clearance for its SpiderFX system to treat severely calcified lesions in the lower extremities.
The Mansfield, Mass.-based med-tech titan’s system has been on the European market since 2005 and is currently the only embolic protection device indicated for use in the lower extremities in the U.S.
Urologix Inc. (NSDQ:ULGX) is heralding the results of a long-term study on its enlarged prostate treatment device.
Data from a study published in The Journal of Urology show that the Minneapolis-based medical device manufacturer’s Cooled ThermoTherapy (CTT) is safe and effective at treating both symptoms and obstruction associated with benign prostatic hyperplasia (BPH), the company reported.
With regulatory approval in hand, Riverain Medical is looking to boost sales of its imaging software that the company says can help radiologists better diagnose lung disease via its “bone suppression technology.”
The Dayton, Ohio-area company last year won 510(k) clearance from the FDA on two imaging software products and has thus far completed about 30 customer installations.
Miamisburg, Ohio-based Riverain Medical tapped Rich Bares to be its new executive vice president of sales and marketing.
The computer-aided detection firm said Bares will be responsible for its global marketing operation for its chest X-ray and CAD-based detection equipment aimed at early-stage lung cancer.
Bares has more than 25 years in the medical imaging field under his belt, according to a press release, with stints at Acuitec LLC, Agfa Healthcare, GE Healthcare, Toshiba Medical Systems and ISG Technologies.
MassDevice Network
@MassDevice
LinkedIn
YouTube